These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15823280)

  • 1. Effect of low-density lipoprotein receptor mutation on lipoproteins and cardiovascular disease risk: a parent-offspring study.
    Koeijvoets KC; Wiegman A; Rodenburg J; Defesche JC; Kastelein JJ; Sijbrands EJ
    Atherosclerosis; 2005 May; 180(1):93-9. PubMed ID: 15823280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population.
    Umans-Eckenhausen MA; Sijbrands EJ; Kastelein JJ; Defesche JC
    Circulation; 2002 Dec; 106(24):3031-6. PubMed ID: 12473547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density lipoprotein receptor genotype and response to pravastatin in children with familial hypercholesterolemia: substudy of an intima-media thickness trial.
    Koeijvoets KC; Rodenburg J; Hutten BA; Wiegman A; Kastelein JJ; Sijbrands EJ
    Circulation; 2005 Nov; 112(20):3168-73. PubMed ID: 16286607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
    Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
    Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double mutant [N543H+2393del9] allele in the LDL receptor gene in familial hypercholesterolemia: effect on plasma cholesterol levels and cardiovascular disease.
    Castillo S; Reyes G; Tejedor D; Mozas P; Suarez Y; Lasuncion MA; Cenarro A; Civeira F; Alonso R; Mata P; Pocovi M;
    Hum Mutat; 2002 Dec; 20(6):477. PubMed ID: 12442279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
    J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.
    Alonso R; Andres E; Mata N; Fuentes-Jiménez F; Badimón L; López-Miranda J; Padró T; Muñiz O; Díaz-Díaz JL; Mauri M; Ordovás JM; Mata P;
    J Am Coll Cardiol; 2014 May; 63(19):1982-9. PubMed ID: 24632281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial Hypercholesterolemia in Greek children and their families: genotype-to-phenotype correlations and a reconsideration of LDLR mutation spectrum.
    Mollaki V; Progias P; Drogari E
    Atherosclerosis; 2014 Dec; 237(2):798-804. PubMed ID: 25463123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between apolipoprotein(a) phenotype, lipoprotein(a) concentration in plasma, and low density lipoprotein receptor function in a large kindred with familial hypercholesterolemia due to the pro664----leu mutation in the LDL receptor gene.
    Soutar AK; McCarthy SN; Seed M; Knight BL
    J Clin Invest; 1991 Aug; 88(2):483-92. PubMed ID: 1830890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
    Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
    Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular basis of familial hypercholesterolemia in the Czech Republic: spectrum of LDLR mutations and genotype-phenotype correlations.
    Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
    Atherosclerosis; 2012 Aug; 223(2):401-8. PubMed ID: 22698793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia.
    Santos PC; Morgan AC; Jannes CE; Turolla L; Krieger JE; Santos RD; Pereira AC
    Atherosclerosis; 2014 Mar; 233(1):206-10. PubMed ID: 24529145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics and kinetics of familial hypercholesterolemia, with the special focus on FH-(Marburg) p.W556R.
    Soufi M; Kurt B; Schweer H; Sattler AM; Klaus G; Zschocke J; Schaefer JR
    Atheroscler Suppl; 2009 Dec; 10(5):5-11. PubMed ID: 20129366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tendon xanthomas in familial hypercholesterolemia are associated with cardiovascular risk independently of the low-density lipoprotein receptor gene mutation.
    Civeira F; Castillo S; Alonso R; Meriño-Ibarra E; Cenarro A; Artied M; Martín-Fuentes P; Ros E; Pocoví M; Mata P;
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1960-5. PubMed ID: 16020744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of receptor negative versus receptor defective mutations in the LDL-receptor gene to angiographically assessed coronary artery disease among young (25-49 years) versus middle-aged (50-64 years) men.
    Gaudet D; Vohl MC; Couture P; Moorjani S; Tremblay G; Perron P; Gagné C; Després JP
    Atherosclerosis; 1999 Mar; 143(1):153-61. PubMed ID: 10208490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype of the mutant LDL receptor allele is associated with LDL particle size heterogeneity in familial hypercholesterolemia.
    Hogue JC; Lamarche B; Gaudet D; Tremblay AJ; Després JP; Gagné C; Couture P
    Atherosclerosis; 2006 Jan; 184(1):163-70. PubMed ID: 15899484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers.
    Besseling J; Kindt I; Hof M; Kastelein JJ; Hutten BA; Hovingh GK
    Atherosclerosis; 2014 Mar; 233(1):219-23. PubMed ID: 24529147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations of the atherogenic Lp(a) are elevated in FH.
    Lingenhel A; Kraft HG; Kotze M; Peeters AV; Kronenberg F; Kruse R; Utermann G
    Eur J Hum Genet; 1998 Jan; 6(1):50-60. PubMed ID: 9781014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia.
    Guardamagna O; Restagno G; Rolfo E; Pederiva C; Martini S; Abello F; Baracco V; Pisciotta L; Pino E; Calandra S; Bertolini S
    J Pediatr; 2009 Aug; 155(2):199-204.e2. PubMed ID: 19446849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.